Gilead Sciences Inc
XHAM:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
C
|
Cheniere Energy Inc
SWB:CHQ1
|
US |
|
Taskus Inc
F:6VY
|
US |
|
E
|
Emerson Electric Co
SWB:EMR
|
US |
|
C
|
Cadence Design Systems Inc
LSE:0HS2
|
US |
|
O
|
Odd Burger Corp
XTSX:ODD
|
CA |
|
S
|
Stef SA
PAR:STF
|
FR |
|
A
|
ASM International NV
OTC:ASMIY
|
NL |
|
Tempur Sealy International Inc
NYSE:TPX
|
US |
|
C
|
Croda International PLC
SWB:6CMB
|
UK |
|
N
|
Nippon Steel Corp
SWB:NPS
|
JP |
|
H
|
Heidelberg Pharma AG
LSE:0QW5
|
DE |
|
Tsingtao Brewery Co Ltd
SSE:600600
|
CN |
|
Big 5 Sporting Goods Corp
NASDAQ:BGFV
|
US |
|
Medical Developments International Ltd
ASX:MVP
|
AU |
|
Qingdao Port International Co Ltd
SSE:601298
|
CN |
|
G
|
Gladstone Commercial Corp
F:GLE
|
US |
|
A
|
Ares Capital Corp
XBER:9A2
|
US |
|
JAFCO Group Co Ltd
OTC:JFKOF
|
JP |
|
Lumine Group Inc
F:Z76
|
CA |
|
T
|
Travelzoo
F:TXM1
|
US |
|
Darktrace PLC
F:7TJ
|
UK |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
30.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 20.9B USD. This includes both short-term (0 USD) and long-term (20.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
